Hereditary blindness caused by a progressive degeneration of the light-sensing cells in the eye, the photoreceptors, affects millions of people worldwide.
Although the light-sensing cells are lost, cells in deeper layers of the retina, which normally cannot sense light, remain intact. A promising new therapeutic approach based on a technology termed “optogenetics” is to introduce light-sensing proteins into these surviving retinal cells, turning them into “replacement photoreceptors” and thereby restoring vision. However, several factors limit the feasibility of a clinical optogenetic therapy using traditional light-sensitive proteins, as they require unnaturally high and potentially harmful light intensities and employ a foreign signaling mechanism within the target retinal cells.
New research publishing May 7th in the Open Access journal PLOS Biology from van Wyk and colleagues demonstrates how optogenetic proteins can be tailored to bring this promising technology closer to medical application. “We were asking the question, ‘Can we design light-activatable proteins that gate specific signaling pathways in specific cells?’, in other words, can the natural signaling pathways of the target cells be retained and just modified in a way to be turned on by light instead of a neurotransmitter released from a preceding neuron?” says Dr. Sonja Kleinlogel, corresponding author of the paper (whose research group is based at the University of Berne, Switzerland). The aim of molecular engineering was to achieve maximal compatibility with native signaling whilst retaining all the advantages of traditional optogenetic proteins, such as fast kinetics and resistance to bleaching by light.
The novel light-sensing protein, termed Opto-mGluR6, is a chimeric protein composed of the light-sensing domains of the retinal photopigment melanopsin and the ON-bipolar cell-specific metabotropic glutamate receptor mGluR6, which is naturally activated by glutamate released from the photoreceptors and amplifies the incoming signal through a coupled intracellular enzymatic pathway. Unlike rhodopsin, for example, the “light antenna” of melanopsin is resistant to bleaching. In other words, the response strength of Opto-mGluR6 never attenuates, no matter how often and hard the protein is hit by light. Moreover, since Opto-mGluR6 is a chimeric protein consisting of two “local” retinal proteins it is also likely to be “invisible” to the immune system, another improvement over traditional optogenetic proteins.
In their study van Wyk and colleagues targeted the retinal ON-bipolar cells, which naturally receive direct input from the photoreceptors. Targeting the surviving cells at the top end of the visual cascade has the advantage that signal computation of the retina is maximally utilized. Turning the native chemical receptor (mGluR6) into a light-activated receptor ensures conservation of native signaling within the ON-bipolar cells, conferring high light-sensitivity and fast “normal” responsiveness. In their study they show proof-of-principle that mice suffering from Retinitis pigmentosa can be treated to regain daylight vision. “The new therapy can potentially restore sight in patients suffering from any kind of photoreceptor degeneration” says Dr. Kleinlogel, “for example also those suffering from severe forms of age-related macular degeneration, a very common disease that affects to some degree about one in every 10 people over the age of 65”.
“The major improvement of the new approach is that patients will be able to see under normal daylight conditions without the need for light intensifiers or image converter goggles”
Read more: Light in sight: a step towards a potential therapy for acquired blindness
The Latest on: Optogenetics
[google_news title=”” keyword=”Optogenetics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Optogenetics
- Development of bio-friendly transparent temperature sensor technology that precisely measures temperature changes by lighton January 8, 2023 at 10:23 am
Engineers have announced the development of a transparent temperature sensor capable of precisely and quickly measuring temperature changes caused by light. This technology is expected to contribute ...
- Ed Boyden and Optogenetics: The Future of Neuroscienceon January 7, 2023 at 4:00 pm
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
- Roundworms' anti-aging could help researchers to stop human agingon January 2, 2023 at 6:39 am
Roundworms, which have an average lifespan of just two to three weeks, are frequently used in aging studies. This means that it is usually possible to receive study results swiftly. Researchers sought ...
- Solar-powered cells: Light-activated proton pumps generate cellular energy, extend lifeon December 30, 2022 at 8:55 am
New research in the journal Nature Aging takes a page from the field of renewable energy and shows that genetically engineered mitochondria can convert light energy into chemical energy that cells can ...
- Optogenetics Actuators and Sensors Market Size (2022 - 2028): Its Selling Price, Production Cost, Growth Opportunity, and Top Key Players.on December 27, 2022 at 6:36 pm
Optogenetics actuators and sensors are devices that can be used to control the activity of cells with light. Optogenetics is a relatively new technology that has been rapidly expanding its ...
- A DIY Optogenetics Device That Costs $10on December 27, 2022 at 4:00 pm
The first completely implantable optogenetics stimulator has a price point so low that research labs with tight budgets can afford to investigate the technology. Now, Ada Poon, PhD, a Stanford ...
- Optogenetics For 100 Euroson December 13, 2022 at 4:00 pm
Larval zebrafish, Drosophila (fruit fly), and Caenorhabditis elegans (roundworm) have become key model organisms in modern neuroscience due to their low maintenance costs and easy sharing of ...
- Optogenetics Market Production Growth, Demand and Supply Analysis 2023 to 2028 |96 Pages Reporton December 7, 2022 at 4:00 pm
Dec 08, 2022 (The Expresswire) -- [Latest 96 Report Sheet] Optogenetics Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast to 2028 guide to light the excellent ...
- cOpn5 optogenetics effectively activates astrocytes (IMAGE)on May 18, 2022 at 7:06 am
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
- New Study Implies Memories Can Be Rewritten Using Optogeneticson February 23, 2016 at 7:37 am
To alter the positive association that the mice have since attached to it, the scientists used a genetic technique called optogenetics, where living brain cells are controlled using fiber optic ...
via Bing News